Tech Company Financing Transactions

Sera Prognostics Funding Round

Blue Ox Healthcare Partners, Catalyst Health Ventures and Chione participated in a $36 million Series D funding round for Sera Prognostics. This venture round was announced on 11/14/2019.

Transaction Overview

Company Information

Company Status

Publicly-held

Industry

Biopharmaceutical

Mailing Address

2749 East Parleys Way 200
Salt Lake City, UT 84109
USA

Phone

(801) 990-0520

Website

www.seraprognostics.com

Email Address

[email protected]

Overview

Sera Prognostics, Inc., was founded in January 2008 to develop diagnostic tests for early prediction of preterm birth, preeclampsia and other pregnancy complications.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Gregory Critchfield

        

Chief Financial Officer

Jay Moyes

        

Chief Information Officer

Robert Harrison

        

Chief Scientific Officer

Jay Boniface

        

Vice President

Thomas Garite

        

VP - Bus. Development

Nadia Altomare

        

VP - Bus. Development

Douglas Fisher

        

VP - General Counsel

Benjamin Jackson

        

Browse more venture capital transactions:

Prev: 11/14/2019: HumanFirst venture capital transaction
Next: 11/14/2019: Freshworks venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to report on every notable VC transaction. All VC database entries on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary